Supernus Pharmaceuticals has said its candidate SPN-820, demonstrated a “rapid and substantial” effect in a Phase IIa trial ...

Daryl Brown, who was prescribed the antidepressant Seroxat in childhood because of his Tourette’s syndrome and OCD, tells ...

Meet Astor, a shy terrier on anti-anxiety meds, looking for a calm home. Discover his story and explore different ...

New Delhi: Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator to market a generic medication for seizures. The company has received approval from the US ...

For the first time, scientists have developed a drug that works on both major aggregation-promoting 'hotspots' of the Tau protein in the brain -- a key driver of neurodegeneration. The drug ...

Paxil in 2005, and Zoloft in 2006. Prozac, Luvox, and Wellbutrin have already lost patent protection. However, the extent to which a strategy relying on the use of less costly generic options will ...

Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines. By Stephanie Nolen Stephanie Nolen has covered the global H.I.V. pandemic for more than 25 ...

The Food and Drug Administration (FDA) last week approved Bristol Myers Squibb’s antipsychotic drug Cobenfy (xanomeline and trospium chloride), the first schizophrenia treatment with an entirely new ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.

For Science Quickly, I’m Rachel Feltman. I’m joined today by Marla Broadfoot, a freelance science journalist who recently covered the new drug for Scientific American. Marla, thank you so much ...

Israeli drugmaker Teva Pharmaceuticals (NYSE:TEVA) announced Tuesday the market launch of the first and only U.S. generic for Sandostatin LAR, an antidiarrheal medication marketed by Swiss ...

Generic drugs gave Americans access to effective, cheap prescription medications. It’s saved them trillions of dollars over the past few decades. But there are signs this vital industry may be in deep ...